Chief Operating and Financial Officer, Burberry
Julie trained as a Chartered Accountant and fellow of the Institute of Taxation with KPMG
She joined ICI and then subsequently became part of Astrazeneca for 25 years. She undertook 11 different roles in 4 countries, 3 continents and 4 Functions (Finance, Corporate Strategy, Business Development and Commercial).
Julie undertook roles across all aspects of the healthcare value chain in AstraZeneca ranging from R&D, to Product Strategy & Licensing, Supply Chain and Commercial. She led major change programmes including $1bn efficiency and cost savings programmes in Operations and R&D.
Julie then joined Smith & Nephew as Group CFO at the beginning of 2013 until joining Burberry.
Julie is also a Non-Executive Director (Audit Committee Chair) of Roche, the world’s leading biopharmaceutical company.
She joined Burberry as their COO and CFO in January 2017.